CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-08-02. AI was used for research and drafting; the existence of all 1 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v1.0.
Verdict No. 1956 · Search date 2026-08-02 · Methodology v1.0

Whole perilla leaves,
does it really help with Relief of seasonal allergic-rhinitis symptoms?

30-Second Summary
?
Evidence Grade ? · Safety acceptable
Extracts have been tested, but whole perilla leaves have not been tested in humans for rhinitis symptoms
Perilla leaves are generally safe in ordinary food amounts. People with allergy to perilla or related mint-family plants should watch for oral, skin, or respiratory reactions.
What the
research shows
The grade is ?. Perilla extracts and rosmarinic acid have been tested in humans, but no study was found that fed whole leaves, leaf powder, or juice and measured seasonal allergic-rhinitis symptoms. Extract findings cannot be transferred to food leaves, so there is no score.
What the
ads claim
A positive extract-capsule result is not the same claim as benefit from leaves eaten at a meal. Extraction and standardization can change the delivered dose, and no valid conversion to a few leaves has been established.
*

Useful facts when choosing a product

  • On 2026-08-02, PubMed exact query 「("Perilla frutescens"[Title/Abstract] OR perilla[Title/Abstract] OR shiso[Title/Abstract]) AND (rhinitis[Title/Abstract] OR rhinoconjunctivitis[Title/Abstract] OR pollinosis[Title/Abstract])」 was screened in full. There were 0 eligible whole-leaf studies; extracts, isolated rosmarinic acid, animal, and cell studies were excluded.
  • On 2026-08-02, ClinicalTrials.gov and WHO ICTRP searches combining the plant names with rhinitis, pollinosis, and allergic rhinoconjunctivitis found 0 eligible whole-leaf-alone registrations. Registrations of perilla extract, seed, and multicomponent products exist but were excluded from this count.
  • Takano 2004 was funded by Meiji Seika Kaisha, Ltd., and multiple authors were affiliated with the company's Health and Bioscience Laboratories.
  • On 2026-08-02, 37 searches across KCI, RISS, ScienceON, J-STAGE, CiNii, CNKI, and Wanfang found 0 eligible human studies using fresh leaves, leaf powder, or juice for this outcome.
  • Bencao Gangmu places the su and ren entries in juan 14, the herb section, and explicitly says they were moved there from the vegetable section.
  • Shiliao Bencao describes pounding the fresh leaf with vinegar and applying it externally. Donguibogam records wind-cold and epigastric fullness, not allergic rhinitis.
  • Verdict 260 is C with 45 points for a perilla-leaf extract and eye fatigue. The present question differs in both outcome and whole-food form.
ID

Chamgap Semantic Classification Code

Candidate index · review held

UNK.whole-perilla-or-shiso-leaves.UNK.seasonal-allergic-rhinitis-symptoms.relieve.placebo

Unknown > Whole perilla or shiso leaves > Unknown > seasonal allergic-rhinitis symptoms > Symptom-relief claim > Placebo

An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.

Download semantic index (JSON) · Codebook v1

Gap Measurement · Verdict 1956 · ?
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Human research clearly exists, but the identified rhinitis studies used perilla extract or multicomponent formulations. Takano 2004 randomized 29 people with mild seasonal allergic rhinoconjunctivitis to 200 mg enriched extract, 10 participants; 50 mg enriched extract, 9 participants; or placebo, 10 participants, for 21 days in a double-blind trial. The work was supported by a grant from Meiji Seika Kaisha, Ltd., and multiple authors, including Osakabe, Sanbongi, Yasuda, Natsume, and Baba, were affiliated with Meiji Seika's Health and Bioscience Laboratories. Thus, the rhinitis trial's funding and much of its research team came from the company selling the tested material. No study fed whole perilla leaves as food and measured rhinitis symptoms. This verdict concerns the food itself, not an extract.

02

Why this is classified as ?

No human study measured the claimed outcome after whole-leaf intake, so the grade is ? and the score is null.

Counterpoint. The human extract signal can motivate a food trial but cannot establish efficacy of the leaf itself.

Rejudgment record. Cross-check applied — Multilingual searches found no human study feeding whole perilla leaves and measuring seasonal allergic-rhinitis symptoms

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Seasonal allergic-rhinitis relief from whole perilla leaves?No human study measured this exact food-and-outcome combination.
Symptom response to rosmarinic-acid-enriched perilla extractCA separate formulation tested in a short 29-person trial.
Relief of ocular and nasal allergy symptoms from whole perilla leaves?This has not been measured in humans using whole leaves.

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Takano H et al. 2004Twenty-one-day randomized double-blind placebo-controlled extract trial29 randomized and analyzed: 10 at 200 mg, 9 at 50 mg, and 10 placeboGrant from Meiji Seika Kaisha, Ltd.; multiple authors affiliated with its Health and Bioscience LaboratoriesNasal and ocular symptom diaries and nasal-lavage inflammatory cellsSome symptom responder rates exceeded placebo, but the intervention was enriched extractExcluded from the whole-leaf question because the formulation differs
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-02).

Takano H, Osakabe N, Sanbongi C, et al. Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, inhibits seasonal allergic rhinoconjunctivitis in humans. Exp Biol Med (Maywood). 2004;229(3):247-254. PMID: 14988517. DOI: 10.1177/153537020422900305.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Evidence date: 2026-08-02 · Corrections: none

Cite this verdict

Whole perilla leaves x relief of seasonal allergic-rhinitis symptoms Evidence Grade ? card
[Chamgap] Whole perilla leaves x relief of seasonal allergic-rhinitis symptoms — Evidence Grade ?. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/immunity/whole-perilla-leaves-seasonal-allergic-rhinitis-symptoms/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.